ES2146643T3 - Fenilcarboxamida-isoxazoles y sus sales, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que lo contienen. - Google Patents
Fenilcarboxamida-isoxazoles y sus sales, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que lo contienen.Info
- Publication number
- ES2146643T3 ES2146643T3 ES94402183T ES94402183T ES2146643T3 ES 2146643 T3 ES2146643 T3 ES 2146643T3 ES 94402183 T ES94402183 T ES 94402183T ES 94402183 T ES94402183 T ES 94402183T ES 2146643 T3 ES2146643 T3 ES 2146643T3
- Authority
- ES
- Spain
- Prior art keywords
- group
- carbon atoms
- salts
- contain
- fenilcarboxamida
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 abstract 2
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000002560 nitrile group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
LOS COMPUESTOS DE FORMULA (I): EN LA QUE R1 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO QUE CONTIENE DE 1 A 3 ATOMOS DE CARBONO; R2 REPRESENTA UN GRUPO CICLOALQUILO QUE CONTIENE DE 3 A 6 ATOMOS DE CRBONO; R4 REPRESENTA UN ATOMO DE HALOGENO, UN GRUPO NITRILO, UN GRUPO NITRO, UN GRUPO PO ALQUILOCARBONILO EN C1 EN C3 UN GRUPO NCX3, EN LOS QUE X REPRESENTA UN ATOMO DE HALOGENO, W REPRESENTA UN ATOMO DE OXIGENO O DE AZUFRE Y N REPRESENTA 1, 2 O 3; Y R5 REPRESENTA UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO QUE CONTIENE DE 1 A 3 ATOMOS DE CARBONO O UN GRUPO CICLOALQUILO QUE CONTIENE DE 3 A 6 ATOMOS DE CARBONO; A CONDICION DE QUE SI R5 REPRESENTA UN ATOMO DE HIDROGENO, R4 NO REPRESENTA UN GRUPO H3 O A, ANTIINFLAMATORIA Y ANTITUMORAL. SE DESCRIBEN, ASIMISMO, SUS PROCEDIMIENTOS DE PREPARACION, LAS COMPOSICIONES QUE LOS CONTIENEN Y SU UTILIZACION EN TERAPIA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939320299A GB9320299D0 (en) | 1993-10-01 | 1993-10-01 | Isoxazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2146643T3 true ES2146643T3 (es) | 2000-08-16 |
Family
ID=10742865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94402183T Expired - Lifetime ES2146643T3 (es) | 1993-10-01 | 1994-09-29 | Fenilcarboxamida-isoxazoles y sus sales, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que lo contienen. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5476866A (es) |
| EP (1) | EP0646578B1 (es) |
| JP (1) | JP3723589B2 (es) |
| AT (1) | ATE193531T1 (es) |
| CA (1) | CA2133140C (es) |
| DE (1) | DE69424734T2 (es) |
| DK (1) | DK0646578T3 (es) |
| ES (1) | ES2146643T3 (es) |
| GB (1) | GB9320299D0 (es) |
| GR (1) | GR3034023T3 (es) |
| PT (1) | PT646578E (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5721277A (en) * | 1995-04-21 | 1998-02-24 | Sugen, Inc. | Compounds and methods for inhibiting hyper-proliferative cell growth |
| DE19539638A1 (de) * | 1995-10-25 | 1997-04-30 | Hoechst Ag | Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen |
| US6316479B1 (en) | 1997-05-19 | 2001-11-13 | Sugen, Inc. | Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders |
| CA2302438A1 (en) * | 1997-05-19 | 1998-11-26 | Sugen, Inc. | Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders |
| ATE207065T1 (de) * | 1997-08-08 | 2001-11-15 | Aventis Pharma Gmbh | Kristallform von n-(4-trifluormethylphenyl)-5- methylisoxazol-4-carbonsäureamid |
| US6579880B2 (en) | 2000-06-06 | 2003-06-17 | Ortho-Mcneil Pharmaceutical, Inc. | Isoxazoles and oxadiazoles as anti-inflammatory inhibitors of IL-8 |
| WO2002007783A2 (en) * | 2000-07-20 | 2002-01-31 | Regents Of The University Of Minnesota | Radiolabeled immunotoxins |
| MXPA04000224A (es) | 2001-07-10 | 2005-07-25 | 4Sc Ag | Novedosos compuestos como agentes antiinflamatorios, inmunomoduladores y antiproliferativos. |
| KR20030063046A (ko) * | 2002-01-22 | 2003-07-28 | 주식회사 엘지생명과학 | 엘비84068을 함유하는 염증으로 인한 질환의 예방 및치료용 조성물 및 이를 포함하는 제제 |
| PL209303B1 (pl) | 2002-12-23 | 2011-08-31 | 4Sc Ag | Związek aromatyczny, kompozycja farmaceutyczna zawierająca związek aromatyczny i zastosowanie związku aromatycznego jako środka przeciwzapalnego, immunomodulującego i antyproliferacyjnego |
| UA108760C2 (uk) | 2010-07-01 | 2015-06-10 | Кальцієві солі сполуки як протизапальні, імуномодулюючі та антипроліферативні засоби | |
| AU2014352920A1 (en) | 2013-11-22 | 2016-06-23 | Genzyme Corporation | Novel methods for treating neurodegenerative diseases |
| JP7358373B2 (ja) | 2018-03-16 | 2023-10-10 | イミュニック アクチェンゲゼルシャフト | 抗炎症薬、免疫調節薬及び抗増殖薬としての新規カルシウム塩多形 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL178596C (nl) * | 1975-06-05 | 1986-04-16 | Hoechst Ag | Werkwijze voor het bereiden van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor het bereiden van daarin als geneeskrachtige verbindingen te gebruiken 5-methylisoxazool-4-carbonzuuraniliden. |
| GB8619432D0 (en) * | 1986-08-08 | 1986-09-17 | Lilly Industries Ltd | Pharmaceutical compounds |
| US4935434A (en) * | 1988-01-26 | 1990-06-19 | Bristol-Myers Company | Antiarthritic isoxazole-4-carboxamides |
| GB9209330D0 (en) * | 1992-04-30 | 1992-06-17 | Roussel Lab Ltd | Chemical compounds |
-
1993
- 1993-10-01 GB GB939320299A patent/GB9320299D0/en active Pending
-
1994
- 1994-08-22 US US08/293,840 patent/US5476866A/en not_active Expired - Lifetime
- 1994-09-28 CA CA002133140A patent/CA2133140C/en not_active Expired - Lifetime
- 1994-09-29 PT PT94402183T patent/PT646578E/pt unknown
- 1994-09-29 EP EP94402183A patent/EP0646578B1/fr not_active Expired - Lifetime
- 1994-09-29 DK DK94402183T patent/DK0646578T3/da active
- 1994-09-29 ES ES94402183T patent/ES2146643T3/es not_active Expired - Lifetime
- 1994-09-29 DE DE69424734T patent/DE69424734T2/de not_active Expired - Lifetime
- 1994-09-29 JP JP25902694A patent/JP3723589B2/ja not_active Expired - Lifetime
- 1994-09-29 AT AT94402183T patent/ATE193531T1/de active
- 1994-12-05 US US08/350,255 patent/US5506249A/en not_active Expired - Lifetime
-
2000
- 2000-07-26 GR GR20000401711T patent/GR3034023T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69424734D1 (de) | 2000-07-06 |
| DE69424734T2 (de) | 2000-11-16 |
| DK0646578T3 (da) | 2000-10-30 |
| EP0646578A1 (fr) | 1995-04-05 |
| PT646578E (pt) | 2000-09-29 |
| ATE193531T1 (de) | 2000-06-15 |
| CA2133140A1 (en) | 1995-04-02 |
| JPH07149743A (ja) | 1995-06-13 |
| CA2133140C (en) | 2006-07-25 |
| US5506249A (en) | 1996-04-09 |
| JP3723589B2 (ja) | 2005-12-07 |
| GR3034023T3 (en) | 2000-11-30 |
| GB9320299D0 (en) | 1993-11-17 |
| US5476866A (en) | 1995-12-19 |
| EP0646578B1 (fr) | 2000-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68903212D1 (de) | 4-mercapto-butyramide-n-mono- oder n,n-disubstituiert durch ein mono- oder polyhydroxyalkyl-radikal und ihre verwendung als reduktionsmittel zur dauernden verformung von haaren. | |
| ATE9793T1 (de) | 5-oxo- und 5-thioxoproline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| DK387889D0 (da) | Makrolider, og farmaceutiske praeparater med indhold af saadanne forbindelser | |
| ES2146643T3 (es) | Fenilcarboxamida-isoxazoles y sus sales, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que lo contienen. | |
| ATE27283T1 (de) | Photopolymerisierbare massen, deren verwendung fuer zahnaerztliche zwecke, sowie verfahren zur herstellung von zahnersatzteilen, zahnfuellungen und ueberzuegen. | |
| DK297383A (da) | Fremgangsmaade til fremstilling af piperazinderivater | |
| ES2074846T3 (es) | Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. | |
| ES2128519T3 (es) | Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| ES2104090T3 (es) | Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| ATE100808T1 (de) | Aminomethylpiperidinderivate, deren verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
| ATE161717T1 (de) | Antivirale mittel | |
| DE59205450D1 (de) | Salicyl(thio)etherderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung | |
| ES2014482B3 (es) | Nuevas 2-tiazolil imidazo/1,2-a/pirimidinas y sus sales, su procedimiento de preparacion, su aplicacion a titulo de medicamentos y las composiciones que las encierran. | |
| ES2103440T3 (es) | Nuevas amidas y sulfonamidas naftalenicas, procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| GB9209330D0 (en) | Chemical compounds | |
| DE69102477D1 (de) | 3-Aminochroman-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen. | |
| DE69322353D1 (de) | Chromen-Derivate mit einer Trien-Kette zur Verwendung bei der Behandlung der Osteoporose und der entzündlichen Erkrankungen | |
| ES2095726T3 (es) | Piperazinas sustituidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. | |
| ES2123728T3 (es) | Derivados de pirrolo-pirazina de actividad 5-ht3. | |
| BR9808672A (pt) | Composto complexante, uso do mesmo, composição farmacêutica, e, processos para gerar uma imagem de um indivìduo animal animado humano ou não humano, para tratar o mesmo, e para preparar um complexo de um complexante | |
| ES520486A0 (es) | Procedimiento para la preparacion de fenoleteres biciclicos. | |
| ES2016931B3 (es) | Procedimiento de preparación de nuevas amidas alifáticas y cicloalifáticas de piridilalquilaminas o de sus derivados N-óxidos. | |
| ES8702392A1 (es) | Un procedimiento para preparar compuestos heterociclicos, en particular compuestos con un anillo de tiadiazinona | |
| ES2095714T3 (es) | Nuevas amino-alquil-cromonas, sus procedimientos de preparacion y las composiciones farmaceuticas que las contienen. | |
| DE3862083D1 (de) | Salze von 6-piperidino-2,4-diaminopyrimidin-3-oxyd und von derivaten der thiamorpholin-3-on-5-carbonsaeure und deren verwendung in kosmetischen stoffen und als heilmittel. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 646578 Country of ref document: ES |